ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Additional TRAVERSE data on testosterone therapy coming soon
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 260040" data-attributes="member: 13851"><p><strong><em>“Because this was the largest trial ever of testosterone replacement therapy, although the primary point of the trial was cardiovascular safety, we embedded within the trial several efficacy and other sub-studies,” says A. Michael Lincoff, MD.</em></strong></p><p></p><p>[URL unfurl="true"]https://www.urologytimes.com/view/additional-traverse-data-on-testosterone-therapy-coming-soon[/URL]</p><p></p><p><em>In this video, <strong>A. Michael Lincoff, MD,</strong> discusses additional forthcoming data related to the New England Journal of Medicine study, “Cardiovascular Safety of Testosterone-Replacement Therapy.” Lincoff is vice chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine and an interventional cardiologist in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic in Cleveland, Ohio.</em></p><p></p><p></p><p></p><p></p><p><strong>Is there anything you would like to add?</strong></p><p></p><p><em>Yes, I'd like to say, "Stay tuned." Because this was the largest trial ever of testosterone replacement therapy, although the primary point of the trial was cardiovascular safety, we embedded within the trial several efficacy and other sub-studies.<strong> Those are in the process of being submitted for publication and will be coming out. I'm not going to disseminate the results ahead of time, but I will say that there's a very thoughtful paper on prostate safety as well as effects on age-related anemia, sexual function, diabetes, progression from prediabetes to diabetes, and effects on bone fractures. </strong>Some of those were reported at The Endocrine Society annual meeting, but as I said, peer-reviewed publications are underway and we hope that they'll be coming out soon.</em></p></blockquote><p></p>
[QUOTE="madman, post: 260040, member: 13851"] [B][I]“Because this was the largest trial ever of testosterone replacement therapy, although the primary point of the trial was cardiovascular safety, we embedded within the trial several efficacy and other sub-studies,” says A. Michael Lincoff, MD.[/I][/B] [URL unfurl="true"]https://www.urologytimes.com/view/additional-traverse-data-on-testosterone-therapy-coming-soon[/URL] [I]In this video, [B]A. Michael Lincoff, MD,[/B] discusses additional forthcoming data related to the New England Journal of Medicine study, “Cardiovascular Safety of Testosterone-Replacement Therapy.” Lincoff is vice chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine and an interventional cardiologist in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic in Cleveland, Ohio.[/I] [B]Is there anything you would like to add?[/B] [I]Yes, I'd like to say, "Stay tuned." Because this was the largest trial ever of testosterone replacement therapy, although the primary point of the trial was cardiovascular safety, we embedded within the trial several efficacy and other sub-studies.[B] Those are in the process of being submitted for publication and will be coming out. I'm not going to disseminate the results ahead of time, but I will say that there's a very thoughtful paper on prostate safety as well as effects on age-related anemia, sexual function, diabetes, progression from prediabetes to diabetes, and effects on bone fractures. [/B]Some of those were reported at The Endocrine Society annual meeting, but as I said, peer-reviewed publications are underway and we hope that they'll be coming out soon.[/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Additional TRAVERSE data on testosterone therapy coming soon
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top